© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Glaxo Wellcome agreed to pay the University royalties on the worldwide sale of Ziagen, an AIDS-inhibiting drug, University President Mark Yudof announced Tuesday. About two-thirds of the royalty ...
The merger of Wellcome and Glaxo in 1995 left the Wellcome Trust with a 4.7% stake in the new company, Glaxo-Wellcome, and it now has an asset base of more than £12 billion. Research grant ...
Two new drugs from a novel class of antiviral compounds have reached the marketplace in time for the 1999–2000 flu season: Glaxo Wellcome's (London) Relenza, and Hoffmann-La Roche's (Nutley ...
GlaxoSmithKline is to team up with two UK ... is to work with the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute to create the new Centre for Therapeutic ...
in 0.45% sodium chloride injection SP 0.4 mL/min Ceftazidime Glaxo Wellcome 6039T86 2 g (80 mg/mL) in 0.45% sodium chloride injection SP 0.9 mL/min Ceftriaxone Roche 3829 2 g (66.7 mg/mL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback